by Basecamp ResearchDesign antibiotics and prioritise vaccine targets against drug-resistant pathogens using EDEN, Basecamp Research's biological foundation model
EDEN is Basecamp Research's frontier biological foundation model. It is trained on BaseData, the world's largest biological dataset, which contains over 10 billion novel genes from more than a million species. The data was collected across 200+ sampling expeditions in 30+ countries.
This connector gives AgentOne access to two EDEN capabilities:
Antibiotic design (EDEN-AMP): Generate novel antimicrobial peptide candidates with predicted potency against 11 drug-resistant bacterial strains, including MRSA, Acinetobacter baumannii, and Pseudomonas aeruginosa. 97% of EDEN-designed AMPs are active in the lab. One candidate showed efficacy in mice comparable to last-resort antibiotics.
Vaccine target prioritisation (EDEN-Immunogenicity): Predict the probability that a protein-coding antigen will trigger an immune response, using EDEN embeddings with an AUROC of 0.85 on external validation data. This reduces weeks of empirical target selection to a single workflow. Every BaseData sequence is collected under informed-consent and benefit-sharing agreements, and each sequence is traceable to country-specific collection permits. For research use only.